System Maintenance Notice

Please note that maintenance work is scheduled between 4 AM and 5 AM - CET. During this time, you may experience reduced performance. Thanks for your patience.

Thibaud Valentin is an expert in Oncology at Oncopole Claudius Regaud (France). As of October 2026, ScienceLeadR ranks Thibaud Valentin in the top 1% of experts worldwide for Sarcoma. Thibaud Valentin has authored 94 publications, the most recent in 2026, and is an investigator in 25 clinical trials, 13 of them ongoing. SLR score: 719 (community average: 125). How the SLR is computed.

LeadR Profile

Thibaud Valentin Oncopole Claudius Regaud France
719 ScienceLeadR Reputation 719

Unlock

Register Login
Network Map

Oncology

Subspecialties: Surgery - Dermatology - Genetics

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Expert Rankings

Top experts on the MeSH terms this expert works on

Organizations

Career arc: 2013 - 2026
Source: PubMed

Oncopole Claudius Regaud

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 94

Citations

Citations: 919 1st author: 7 Last author: 3 Unique author: 0

Main journals

Ann Oncol 22
J Clin Oncol 10
ESMO Open 5
Eur J Cancer 5
Ann Dermatol Venereol 3

Best Journals

Ann Oncol 17
J Clin Oncol 6
Lancet Oncol 2

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Head & Neck and Shoulder Desmoid-Type Fibromatosis: Presentation and Natural History of These Ultra-Rare Locations.
PMID 42905937 — fibromatosis, aggressive, natural history, pain, neoplasms, history		Cancer Med20260
Long-Term Analysis of Patients With Ewing Sarcoma Included in the Euro-EWING99 Study.
PMID 42537000 — sarcoma, ewing, sarcoma, neoplasm metastasis, therapeutics, prognosis		J Clin Oncol Top journal20262
MiT fusions, TSC1-TSC2 divergence, and stem-like programs reveal distinct origins and vulnerabilities in PEComa.
PMID 42331846 — genes, microscopy, electron, scanning transmission, perivascular epithelioid cell neoplasms, neoplasms, classification, therapeutics, mutation		Nat Commun20260
Validation of the Transcription Association Chromosomal Instability Index Biomarker on RNA Sequencing in Soft Tissue Sarcomas.
PMID 42308462 — neoplasms, biomarkers, sarcoma, precision medicine, therapeutics, tissues, chromosomal instability, prognosis, rna		JCO Precis Oncol20260
Overall survival of patients with localized soft tissue sarcoma treated with or without adjuvant chemotherapy (DEEPSARC): a real world nationwide retrospective cohort study in France.
PMID 42291149 — registries, cohort studies, drug therapy, sarcoma, chemotherapy, adjuvant, work, therapeutics, tissues, aids-related complex, chemotherapy		EClinicalMedicine20263

Clinical Studies 25

Sources: ClinicalTrials, EU CTIS

Synthesis

Principal Investigator: 5

By phase:

Phase 2 11
Phase 3 6
N/A 5
Phase 1/Phase 2 2
Phase 2/Phase 3 1

By status:

Recruiting 17
Completed 5
Active not recruiting 2
Unknown 1

By type:

Interventional 24
Observational 1

By Monocentric/Multicentric:

monocentric 3
multicentric2to4 0
multicentric5to9 4
multicentricup10 18

Main Topics

Cohort/Consortium Investigators 1

Ongoing Clinical Trials

13 ongoing trials started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
INTER EWING 1 International Clinical Research Programme to Improve Outcomes in Newly Diagnosed Ewing Sarcoma Trial 1
2024-511989-36-00 — radiotherapy, sarcoma, ewing, biomedical research, drug therapy, sarcoma, research, chemotherapy		Phase 3Recruiting2025
Interest of post operative chemotherapy in patients with localized uterine leiomyosarcoma suspected to have a high risk of relapse based on a biologic test performed on the tumor
2023-506350-21-00 — leiomyosarcoma, neoplasms, classification, drug therapy, chemotherapy, adjuvant, chemotherapy		Phase 2Recruiting2025
Research of Double positive Circulating Cells (Tumor Marker CD45 ) in Several Types of Metastatic Cancers
NCT06967961 — carcinoma, transitional cell, cells, blood, endometrium, uterine cervical neoplasms, melanoma, neoplasms, adenocarcinoma, prostate, kidney, biopsy, sarcoma, blood volume, germ cells, kidney neoplasms, research, therapeutics, tissues, liquid biopsy, carcinoma		N/ARecruiting2025
Interest of Post operative Chemotherapy in Patients With Localised Uterine Leiomyosarcoma Suspected of Having a High Risk of Recurrence Based on a Biological Test Performed on the Tumour
NCT06524583 — leiomyosarcoma, uterus, doxorubicin, drug therapy, chemotherapy, adjuvant, trabectedin, chemotherapy		Phase 2Recruiting2025
De escalation Study for Stage IIa IIb 3 cm Seminoma
NCT05529251 — radiotherapy, quality of life, safety, micrornas, positron-emission tomography, drug therapy, biomarkers, seminoma, therapeutics, etoposide, carboplatin, chemotherapy		Phase 2Recruiting2022

LeadR Networks

Main global connection map

Sources: PubMed, OpenAlex, ClinicalTrials, EU CTIS